Peridex is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Peridex has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS.

Peridex therapy should be initiated directly following a dental prophylaxis. Patients u sing Peridex should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 15ml (marked in cap) of undiluted Peridex. Patients should be instructed to not rinse with water or other mouthwashes, brush teeth or eat immediately after using Peridex. Peridex is not intended for ingestion and should be expectorated after rinsing.

Peridex is supplied as a blue liquid in the following sizes:

0.5 fluid ounce (15 ml) (NDC 48878-0620-4) amber plastic bottle with child resistant dispensing closure

4 fluid ounce (118 ml) (NDC 48878-0620-3) amber plastic bottles with child resistant dispensing closure

16 fluid ounce or 1 pint (473ml) (NDC 48878-0620-1) amber plastic bottles with child-resistant dispensing closure

64 fluid ounce (1893 ml) (NDC 48878-0620-2) white plastic bottle with pump dispensing closure

STORE ABOVE FREEZING (32°F or 0°C)

Keep out of reach of children

Revised: January/2013. Made in USA for: 3M ESPE Dental Products St. Paul, MN 55144-1000 USA

Last reviewed on RxList: 1/28/2013
This monograph has been modified to include the generic and brand name in many instances.